Kidoz Inc (PK) (KDOZF) News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness...

Form 8-K - Current report

Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that it has received notice of the commencement of...

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 8-K - Current report

Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that it has received confirmation of the issuance of a...

Form 8-K - Current report

Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the Company’s Board of Directors has approved an...

Form 8-K - Current report

Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products

Project investment amounts expected to total $5.4 million with Acenzia investing $600 thousand, Protein Industries Canada investing $2.3 million...

Form 8-K - Current report

Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today the Company and RC Consulting Consortium Group LLC, in...